After Hours
$
128.13
Change
-0.70 -0.54%
Volume
Volume 6,469
Apr 16, 2021, 6:24 p.m.
Quotes are delayed by 20 min
Previous close
$ 125.98
$ 128.83
Change
+2.85 +2.26%
Day low
Day high
$123.71
$129.32

52 week low
52 week high
$106.13
$306.72

Market cap
$5.33B
Average volume
892,281
P/E ratio
6.93
Rev. per Employee
$1.21M
EPS
18.58
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on QDEL
-
Quidel upgraded to outperform from market perform at Raymond James
- Tomi Kilgore
-
Abbott Gets the First Big Orders for Its Fast Covid Test
- Barron's Online
-
The Pandemic Speeds Up the Health-Care Revolution
- Barron's Online
-
Quidel downgraded to underweight from neutral at J.P. Morgan
- Tomi Kilgore
-
Quidel stock price target raised to $158 from $120 at J.P. Morgan
- Tomi Kilgore
-
Trump Team Signals Optimism Sunday, Despite Grim News
- Barron's Online
-
U.S. states move to expand coronavirus testing
- Ben Chapman
-
FDA grants emergency-use status for first coronavirus antigen test
- Thomas M. Burton
-
Bear-market rally accelerates, S&P 500 reclaims latest key technical level
- Michael Ashbaugh
-
Three stocks that are ‘part of the solution’ to the coronavirus crisis
- Philip van Doorn
-
How to profit from the ‘best of both worlds’ in stock investing
- Philip van Doorn
-
Quidel Corp.maintained as strong buy at Raymond James
- Ciara Linnane
-
Quidel Corp. price target cut to $70 from $80 at Raymond James
- Tonya Garcia
-
How to find ‘coming of age’ companies whose stocks could rise 10-fold
- Philip van Doorn
-
Quidel upgraded to strong buy from outperform at Raymond James
- Tomi Kilgore
-
Expect better, more reliable flu tests
- MarketWatch.com
-
- Barron's Online
-
Quidel upgraded to outperform from market perform at Raymond James
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
Other News on QDEL
-
Healthcare Dashboard For April And Focus On IDNA
- Seeking Alpha
-
Quidel: Growth Beyond COVID-19
- Seeking Alpha
-
Best And Worst Performing Midcap Stocks In Q1 2021
- Seeking Alpha
-
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
- InvestorPlace.com
-
FDA Authorizes First Covid-19 Tests for Repeat, at-Home Screening
- Brianna Abbott
-
FDA Authorizes First Covid-19 Tests for Repeat, at-Home Screening
- Brianna Abbott
-
Why Fulgent Genetics Is a Great Stock to Buy Right Now
- Motley Fool
-
These 3 Stocks Will Make You Rethink Your Portfolio
- Motley Fool
-
Covid Fatigue Threatens to Derail Once Relevant Quidel
- InvestorPlace.com
-
Bull of the Day: Meridian Bioscience (VIVO)
- Zacks.com
-
Did 'What Works On Wall Street' Stop Working?
- Seeking Alpha
- Loading more headlines...
Press Releases on QDEL
-
Quidel Partners With San Diego Padres Organization for COVID-19 Testing
- BusinessWire - BZX
-
Quidel Supports New NIH, CDC Public Health Initiative for At-home COVID-19 Testing
- BusinessWire - BZX
-
Quidel Corporation Applauds Biden Administration Plan to Expand COVID-19 Testing
- BusinessWire - BZX
-
Should Investors Be Watching These Top Health Care Stocks Right Now?
- StockMarket.com
-
Quidel Receives Emergency Use Authorization for QuickVue® At-Home COVID-19 Test
- BusinessWire - BZX
-
Tuesday 2/23 Insider Buying Report: QDEL, XAIR
- MarketNewsVideo.com
-
Tuesday's ETF with Unusual Volume: XMMO
- MarketNewsVideo.com
-
Quidel to Present at Upcoming Conferences
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com